These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38039046)

  • 1. A comprehensive prognostic analysis of cause-specific mortality in patients with ovarian serous cystadenocarcinoma using a competing-risks model: a case study of the SEER database.
    Chong SM; Li YJ; He Y; Chokkakula S; Ming WK; Leong NC; Zhao QQ; Chen WH; Huang CD; Deng LH; Lyu J
    Eur Rev Med Pharmacol Sci; 2023 Nov; 27(22):11143-11155. PubMed ID: 38039046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competing-Risks Model for Predicting the Postoperative Prognosis of Patients with Papillary Thyroid Adenocarcinoma Based on The Surveillance, Epidemiology, and End Results (SEER) Database.
    Bian F; Li C; Han D; Xu F; Lyu J
    Med Sci Monit; 2020 Jul; 26():e924045. PubMed ID: 32710734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Competing Risk Analysis Study of Prognosis in Patients with Esophageal Carcinoma 2006-2015 Using Data from the Surveillance, Epidemiology, and End Results (SEER) Database.
    Yu Z; Yang J; Gao L; Huang Q; Zi H; Li X
    Med Sci Monit; 2020 Jan; 26():e918686. PubMed ID: 31966000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competing-risks analysis for evaluating the prognosis of patients with microinvasive cutaneous squamous cell carcinoma based on the SEER database.
    Zheng S; Xie S; Yu H; Duan X; He Y; Ho C; Wan Y; Hang T; Chen W; Lyu J; Deng L
    BMC Med Res Methodol; 2023 Dec; 23(1):286. PubMed ID: 38062392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competing-risks nomograms for predicting cause-specific mortality in parotid-gland carcinoma: A population-based analysis.
    Xu F; Feng X; Zhao F; Huang Q; Han D; Li C; Zheng S; Lyu J
    Cancer Med; 2021 Jun; 10(11):3756-3769. PubMed ID: 33960711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and identification of a prognostic nomogram model for patients with mixed cell adenocarcinoma of the ovary.
    Wu H; Jiang S; Zhong P; Li W; Zhang S
    J Ovarian Res; 2021 Oct; 14(1):137. PubMed ID: 34674727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competitive Risk Analysis of Prognosis in Older Adults with Sigmoid Colon Adenocarcinoma: A Population-Based Study.
    Du R; Guo J; Li J; Lyu J; Lyu L
    Cancer Control; 2024; 31():10732748241262184. PubMed ID: 38868954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competitive Risk Analysis of Prognosis in Patients With Cecum Cancer: A Population-Based Study.
    Wu W; Yang J; Li D; Huang Q; Zhao F; Feng X; Yan H; Lyu J
    Cancer Control; 2021; 28():1073274821989316. PubMed ID: 33491489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in patients with gastric adenocarcinoma using competing-risk analysis: a study of cases in the SEER database.
    Zhang X; Yang J; Huang Q; Lyu J
    Scand J Gastroenterol; 2019 Aug; 54(8):1015-1021. PubMed ID: 31382800
    [No Abstract]   [Full Text] [Related]  

  • 10. Nomogram to predict cause-specific mortality of patients with rectal adenocarcinoma undergoing surgery: a competing risk analysis.
    Zhang X; Xu F; Bin Y; Liu T; Li Z; Guo D; Li Y; Huang Q; Lyu J; He S
    BMC Gastroenterol; 2022 Feb; 22(1):57. PubMed ID: 35144545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of lymph node ratio in stage IIIC epithelial ovarian cancer with node-positive in a SEER population-based study.
    Zhou J; He ZY; Li FY; Sun JY; Lin HX; Wu SG; Chen QH
    Oncotarget; 2016 Feb; 7(7):7952-9. PubMed ID: 26788911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for squamous cervical carcinoma identified by competing-risks analysis: A study based on the SEER database.
    Hu C; Cao J; Zeng L; Luo Y; Fan H
    Medicine (Baltimore); 2022 Sep; 101(39):e30901. PubMed ID: 36181049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competing-risks model for predicting the prognosis of penile cancer based on the SEER database.
    Yang J; Pan Z; He Y; Zhao F; Feng X; Liu Q; Lyu J
    Cancer Med; 2019 Dec; 8(18):7881-7889. PubMed ID: 31657120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nomograms for Estimating Cause-Specific Death Rates of Patients With Inflammatory Breast Cancer: A Competing-Risks Analysis.
    Xu F; Yang J; Han D; Huang Q; Li C; Zheng S; Wang H; Lyu J
    Technol Cancer Res Treat; 2021; 20():15330338211016371. PubMed ID: 34013802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences between primary peritoneal serous carcinoma and advanced serous ovarian carcinoma: a study based on the SEER database.
    Li X; Yang Q; Chen M; Yang C; Gu J; Dong Q; Yang G
    J Ovarian Res; 2021 Feb; 14(1):40. PubMed ID: 33640000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nomogram to Predict Cause-Specific Mortality in Patients With Surgically Resected Stage I Non-Small-Cell Lung Cancer: A Competing Risk Analysis.
    Zhou H; Zhang Y; Qiu Z; Chen G; Hong S; Chen X; Zhang Z; Huang Y; Zhang L
    Clin Lung Cancer; 2018 Mar; 19(2):e195-e203. PubMed ID: 29153966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causes of death and effect of non-cancer-specific death on rates of overall survival in adult classic Hodgkin lymphoma: a populated-based competing risk analysis.
    Gao J; Chen Y; Wu P; Wang F; Tao H; Shen Q; Wang S; Gong S; Zhang X; Zhou Z; Song X; Jia Y
    BMC Cancer; 2021 Aug; 21(1):955. PubMed ID: 34433456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in patients with gallbladder adenocarcinoma identified using competing-risks analysis: A study of cases in the SEER database.
    Han D; Yang J; Xu F; Huang Q; Bai L; Wei YL; Kaaya RE; Wang S; Lyu J
    Medicine (Baltimore); 2020 Jul; 99(31):e21322. PubMed ID: 32756116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy is not necessary for early-stage serous and endometrioid ovarian cancer after undergoing comprehensive staging surgery.
    Li S; Zhu Z
    J Ovarian Res; 2020 Aug; 13(1):91. PubMed ID: 32772926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prevalence, Associated Factors for Lung Metastases Development and Prognosis in Ovarian Serous Cancer Based on SEER Database.
    Cao C; Yang X
    Technol Cancer Res Treat; 2020; 19():1533033820983801. PubMed ID: 33356997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.